» Articles » PMID: 24535531

Open Letter to the Executive Director of the European Medicines Agency Concerning the Licensing of Hydroxyethyl Starch Solutions for Fluid Resuscitation

Overview
Journal Br J Anaesth
Publisher Elsevier
Specialty Anesthesiology
Date 2014 Feb 19
PMID 24535531
Citations 6
Authors
Affiliations
Soon will be listed here.
Citing Articles

Time and Type of Administered Fluids during Cesarean Section Might Not Matter for Hemodynamic Outcomes, but There Are Significant Patient Safety Concerns Regarding Colloid Use in Parturients. Comment on Theodoraki et al. Colloid Preload versus....

Akca B, Bilotta F J Clin Med. 2023; 12(14).

PMID: 37510867 PMC: 10381353. DOI: 10.3390/jcm12144753.


Starch Wars-New Episodes of the Saga. Changes in Regulations on Hydroxyethyl Starch in the European Union.

Adamik K, Yozova I Front Vet Sci. 2019; 5:336.

PMID: 30713845 PMC: 6345713. DOI: 10.3389/fvets.2018.00336.


Intraoperative hydroxyethyl starch 70/0.5 administration may increase postoperative bleeding: a retrospective cohort study.

Fukushima T, Uchino S, Fujii T, Takinami M, Uezono S J Anesth. 2017; 31(3):330-336.

PMID: 28341919 DOI: 10.1007/s00540-017-2334-2.


Comparison of hydroxyethyl starch regulatory summaries from the Food and Drug Administration and the European Medicines Agency.

Wiedermann C, Eisendle K J Pharm Policy Pract. 2017; 10:12.

PMID: 28331624 PMC: 5359805. DOI: 10.1186/s40545-016-0090-6.


Use of perioperative hydroxyethyl starch 6% and albumin 5% in elective joint arthroplasty and association with adverse outcomes: a retrospective population based analysis.

Opperer M, Poeran J, Rasul R, Mazumdar M, Memtsoudis S BMJ. 2015; 350:h1567.

PMID: 25817299 PMC: 4376265. DOI: 10.1136/bmj.h1567.